about
Sequence-Defined Oligomers from Hydroxyproline Building Blocks for Parallel Synthesis Applications.Contaminants in commercial preparations of 'purified' small leucine-rich proteoglycans may distort mechanistic studies.Recent developments in capillary and microchip electroseparations of peptides (2013-middle 2015).The role of intramolecular self-destruction of reactive metabolic intermediates in determining toxicity.Quantification of a peptide standard using the intrinsic fluorescence of tyrosineQuality evaluation of synthetic quorum sensing peptides used in R&D.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Related impurities in peptide medicines.
@en
type
label
Related impurities in peptide medicines.
@en
prefLabel
Related impurities in peptide medicines.
@en
P2093
P1476
Related impurities in peptide medicines
@en
P2093
Bert Gevaert
Evelien Wynendaele
Frederick Verbeke
Lien Taevernier
Matthias D'Hondt
Nathalie Bracke
P356
10.1016/J.JPBA.2014.06.012
P577
2014-06-13T00:00:00Z